Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barre or Miller Fisher syndrome

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 729-733

  Jacobs, Bart C ^a,b   Hazenberg, Maarten P ^a   Van Doorn, Pieter A ^a   Endtz, Hubert Ph ^a   Van Der Meché, Frans G A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN; CROSS REACTING ANTIBODY; EPITOPE; GANGLIOSIDE ANTIBODY; SIALIDASE;

ANTIBODY DETECTION; ARTICLE; BACTERIUM ISOLATION; BINDING AFFINITY; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME;

EID: 0031034454     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.729     Document Type: Article

References (15)

1. Jacobs BC, van Doom PA, Schmilz PIM, et al. Campylobacter jejuni infections and anti-GMl antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-7.
2. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQIb IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohisto-chemical studies. Neurology 1993;43:1911-7.
3. Ogawa-Goto K, Funamoto N, Ohta Y, Abe T. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 1992;59: 1844-9.
4. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-53.
5. Jacobs BC, Endtz HPh, van der Meché FGA, Hazenberg MP, Achtereekte HAM, van Doom PA. Serum anti-GQlb IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260-4.
6. Oomes PG, Jacobs BC, Hazenberg MPH, Bänffer JRJ, van der Meche ́ FGA. Anti-GMl IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol 1995; 38:170-5.
7. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-5.
8. Asbury AK, Comblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):S21-4.
9. Westphal O, Jann K. Bacterial lipopolysaccharides, extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965;5:83-91.
10. Schwerer B, Neisser A, Polt RJ, Bernheimer H, Moran AP. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacler jejuni serotypes associated with Guillain-Barré syndrome. J Endotoxin Res 1995;2:395-403.
11. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQlb ganglioside and lipopolysaccharides of Campylobacler jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994; 36:791-3.
12. Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1995; 130:112-6.
13. Mandrell RE, Apicella MA. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 1993;187:382-402.
14. Willison HJ, Kennedy PGE. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol 1993;46:105-12.
15. Wirguin I, Suturkova-Milosevic LJ, Della-Latta P, Fisher T, Brown RH, Latov N. Monoclonal IgM antibodies to GM1 and asialo-GMl in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann Neurol 1994;35:698-703.